Dr. Jeremy O’Connell, our CSO, participated as a panelist at the Gerontological Society of America (GSA) Annual Meeting, discussing the role of NIA programs in advancing JUV-161 from discovery to development and fostering innovation in aging research.
Thach Mai, Director of Discovery and Platform, and Priya Handa, Director of Translational Biology, were speakers at the 16th Drug Discovery Strategic Summit in San Francisco. Thach presented on our AI-enabled platform for therapeutic discovery, while Priya spoke about JUV-112, a novel approach to weight loss and metabolic health.
CEO Dr. Hanadie Yousef discusses Juvena’s AI-enabled proteomics and multimodal platform for decoding therapeutic secreted proteins on the “Leveraging Technology to Advance the Pipeline” panel at Longwood’s Boston CEO summit
Juvena is delighted to have had the opportunity to participate in our investor Bison’s AGM. CEO Dr. Yousef was on a panel focused on discussing the latest innovations in AI-driven drug discovery and development
CEO, Dr. Hanadie Yousef inspires the next generation of biotech entrepreneurs, in a fireside chat: Targeting the biology of aging to rejuvenate lives- Dr. Yousef’s journey through science research to launching Juvena for the Global Biotech Revolution
CEO Dr. Yousef represents Juvena as a Technology Pioneer at at the World Economic Forum’s Annual Meeting of the New Champions, a.k.a. Summer Davos, in Dalian, China, speaking on “Revolutionary Remedies” and “Letting Biotech Breath”
CEO Dr. Hanadie Yousef gives a talk on Juvena’s AI-enabled protein drug discovery and development platform and lead therapeutic candidates for muscle regeneration and enhancing fat metabolism at the Longevity Summit Dublin
CEO Dr. Hanadie Yousef represents Juvena on 2 panels at BIO San Diego to discuss navigating the frontiers of First-in-Class therapeutics, and how healthspan promoting therapeutics are entering the biopharma mainstream.
